Picture of DexCom logo

DXCM DexCom Income Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousLarge CapHigh Flyer

Annual income statement for DexCom, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2019
December 31st
R2020
December 31st
R2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Revenue
Total Revenue1,4761,9272,4492,9103,622
Cost of Revenue
Gross Profit9461,3051,7091,8972,306
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses1,3341,6272,1832,5193,025
Operating Profit142300266391598
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes104298257391710
Provision for Income Taxes
Net Income After Taxes101550217341542
Net Income Before Extraordinary Items
Extraordinary Items
Net Income101550217341542
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income101550217341542
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS0.3381.370.610.8311.3